HomeAI · summaries
Storia in 8 fonti
FDA approves Eli Lilly's GLP-1 weight-loss pill Foundayo - UPI.com
The Food and Drug Administration on Wednesday approved Eli Lilly's pill version of a GLP-1 medication for weight loss.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
forbes.com
FDA Approves Eli Lilly’s Weight Loss Pill Foundayo—Fewer Food And Drink Restrictions
Lilly says Foundayo was approved to treat obesity and can lead to long-term weight loss, alongside diet and exercise.
- ·
cnbc.com
FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market
The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market.
- ·
ft.com
Eli Lilly wins US approval for weight-loss drug in pill form
New drug Foundayo sets up battle with Novo Nordisk for oral obesity drugs
- ·
upi.com
FDA approves Eli Lilly's GLP-1 weight-loss pill Foundayo - UPI.com
The Food and Drug Administration on Wednesday approved Eli Lilly's pill version of a GLP-1 medication for weight loss.
- ·
usatoday.com
Eli Lilly wins approval for new weight-loss pill. What to know.
Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.
- ·
wired.com
FDA Approves Eli Lilly’s GLP-1 Pill
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
- ·
ilpost.it
Negli Stati Uniti è stato approvato un farmaco dimagrante di Eli Lilly sotto forma di pillola
Dopo aver eseguito alcuni test, Eli Lilly ha detto che Foundayo permette di perdere circa il 12-15 per cento del peso corporeo: è meno di quanto permetta la versione iniettabile…
- ·
Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison
Novo and Eli Lilly are both trying to shape the narrative of their rival pills, considered to be the start of the next phase of the weight-loss drug era.
- ·
wired.it
Come funziona Foundayo, il nuovo farmaco dimagrante in pillole appena approvato negli Stati Uniti
Prodotto dalla casa farmaceutica Eli Lilly, la compressa fa parte dei medicinali anti-obesità Glp-1, la stessa categoria di Ozempic e Wegovy